Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MCI-196 (Colestilan) in dialysis patients with hyperphosphatemia
NCT00772382Phase 3Completed
- Sponsor
- Mitsubishi Tanabe Pharma
- Start
- Dec 2008
- Primary completion
- Aug 2010
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of colestilan in hyperphosphatemia, sponsored by Mitsubishi Tanabe Pharma. Started Dec 2008; status: completed.
02
Drugs
colestilan
03
Conditions
hyperphosphatemia
Beyond the preview
Go deeper on NCT00772382.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00772382.